MarketCap
Facebook
X
TelegramAnnual report 2024
added 01-24-2026
Alcon Total Non Current Liabilities 2011-2026 | ALC
Annual Total Non Current Liabilities Alcon
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 6.05 B | 2.53 B | 2.58 B | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.05 B | 2.53 B | 3.72 B |
Quarterly Total Non Current Liabilities Alcon
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 6.27 B | - | 6.48 B | - | 6.52 B | - | 6.63 B | - | 6.05 B | - | 4.5 B | - | 2.53 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.63 B | 2.53 B | 5.57 B |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
7.05 B | $ 19.93 | 0.99 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 8.71 | 3.75 % | $ 176 M | USA |
 |
AtriCure
ATRC
|
261 M | $ 36.37 | -1.57 % | $ 1.71 B | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 5.37 | -1.56 % | $ 245 M | USA |
 |
Haemonetics Corporation
HAE
|
405 M | $ 65.87 | -0.15 % | $ 3.32 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 6.83 | -3.73 % | $ 37.7 K | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 10.2 | 2.2 % | $ 417 M | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 149.04 | -0.66 % | $ 3.63 B | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 8.14 | 1.12 % | $ 168 M | USA |
 |
The Cooper Companies
COO
|
1.54 B | $ 80.95 | 0.72 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
56 M | $ 134.5 | -1.29 % | $ 7.17 B | USA |
 |
Harvard Bioscience
HBIO
|
58.5 M | $ 0.5 | -7.06 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 117.26 | -1.43 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
OraSure Technologies
OSUR
|
35.8 M | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 150.09 | 0.74 % | $ 4.68 B | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 84.08 | 0.26 % | $ 1.89 B | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 505.88 | -0.33 % | $ 180 B | USA |
 |
STERIS plc
STE
|
1.53 B | $ 261.25 | -0.23 % | $ 25.8 B | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 1.84 | -1.34 % | $ 18.8 M |  Israel |
 |
Nephros
NEPH
|
1.61 M | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 60.16 | -2.42 % | $ 218 M | USA |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.29 | -0.7 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 23.07 | -1.28 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 38.84 | -1.43 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 13.69 | 0.48 % | $ 658 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25 B | $ 201.67 | 0.29 % | $ 58 B | USA |
 |
Repligen Corporation
RGEN
|
701 M | $ 151.86 | -2.88 % | $ 8.46 M | USA |
 |
ResMed
RMD
|
1.05 B | $ 251.52 | -2.37 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 22.08 | -2.21 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 2.26 | -3.21 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 18.79 | -0.8 % | $ 923 M | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 105.0 | -0.43 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 226.43 | -2.61 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 12.28 | 0.04 % | $ 2.5 B | USA |